Total submissions: 11
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000039747 | SCV000063436 | likely benign | not specified | 2013-02-07 | criteria provided, single submitter | clinical testing | p.Pro1752del in exon 33 of PCDH15: This variant is not expected to have clinical significance because it has been seen in 0.6% (5/878) of control chromosomes (S tabej 2012) and results in an in-frame deletion of a Pro residue in a non-conser ved proline tract. |
Eurofins Ntd Llc |
RCV000415971 | SCV000114271 | uncertain significance | not provided | 2013-08-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV004577721 | SCV000363126 | uncertain significance | Hearing loss, autosomal recessive | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000360567 | SCV000363127 | uncertain significance | Retinitis pigmentosa-deafness syndrome | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000415971 | SCV000493571 | likely benign | not provided | 2024-11-01 | criteria provided, single submitter | clinical testing | PCDH15: BS1:Supporting, BS2 |
Gene |
RCV000415971 | SCV000570036 | likely benign | not provided | 2023-09-25 | criteria provided, single submitter | clinical testing | See Variant Classification Assertion Criteria. |
Labcorp Genetics |
RCV000415971 | SCV001047495 | likely benign | not provided | 2025-01-28 | criteria provided, single submitter | clinical testing | |
Clinical Genetics, |
RCV000415971 | SCV001921678 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000415971 | SCV001967962 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Natera, |
RCV001826582 | SCV002091023 | benign | Usher syndrome type 1F | 2019-09-25 | no assertion criteria provided | clinical testing | |
Prevention |
RCV004534844 | SCV004726359 | likely benign | PCDH15-related disorder | 2020-09-16 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |